NCT03053830View on ClinicalTrials.gov

Open Label Ketamine Treatment for Major Depressive Disorder in Veterans

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

September 26, 2018

Study Completion Date

September 26, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

Ketamine

0.5mg/kg ketamine in normal saline. Infusion will be delivered during a 40 minute interval

Trial Locations (1)

06516

VA Healthcare System, West Haven

All Listed Sponsors
lead

VA Connecticut Healthcare System

FED

NCT03053830 - Open Label Ketamine Treatment for Major Depressive Disorder in Veterans | Biotech Hunter | Biotech Hunter